Kian Esteghamat

MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.

Part of Avancen MOD Corp., Avancen, Inc. manufactures industrial rubber goods, rubberized fabrics, and miscellaneous rubber specialties. The company is based in Palm Coast, FL.

Boston Heart Diagnostics Corp. provides cardiovascular disease clinical services. It specializes in diagnostic testing, personalized treatment recommendations and personalized wellness programs. The company was founded by Bela F. Asztalos and Ernst J. Schaefer in 2007 and is headquartered in Framingham, MA.

TOMA Biosciences, Inc. develops and provides DNA-based cancer testing technology. The company was founded by Hanlee Ji, Lincoln Nadauld, James M. Ford, and Calvin J. Kuo in 2011 and is headquartered in Foster City, CA.

Octant, Inc. operates as a biotechnology company. The company was founded by Sri Kosuri and Ramsey Homsany and is headquartered in Emeryville, CA.

Daum GmbH & Co. KG is a German company that specializes in textile finishing services such as embroidery, laser branding, and transfer printing. The private company was founded in 2002 and is based in Trautskirchen, Germany. The company offers full-service solutions and fast project processing with a focus on high-quality results.

Trident Labs, Inc. engages in the operation of toxicology laboratories. It offers urine and oral fluid drug testing to help medical offices monitor adherence to prescription medication and abstinence from illicit drugs. The company is headquartered in Holland, MI.

AH Capital Management LLC (AH Capital Management) is a venture capital firm founded in 2009 by Marc Lowell Andreessen and Ben A. Horowitz. The firm is headquartered in Menlo Park, California.

twoXAR, Inc. provides drug discovery services. Its DUMA platform rapidly evaluates massive public and proprietary datasets to identify and rank probability drug-disease matches. The company was founded by Andrew A. Radin and Andrew M. Radin in 2014 and is headquartered in Palo Alto, CA.

Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.

Komodo Health, Inc. provides modern healthcare intelligence. The firm provides data engineering, life sciences, predictive analytics, healthcare, professional services, and machine intelligence. The company was founded by Web Sun and Arif Nathoo in 2014 and is headquartered in San Francisco, CA.

Asimov, Inc. develops and operates software platform for biotechnology. Its platform combines computer-aided design, artificial intelligence, and synthetic biology. The company was founded by Christopher Voigt, Douglas Densmore, Alec Neilson, and Raja Srinivas on March 27, 2017 and is headquartered in Cambridge, MA.

Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom.

Dyno Therapeutics, Inc. engages in the development of therapeutics technologies. It develops technologies for safe, efficient and targeted in vivo delivery of new gene therapies and genome editing therapies. The company was founded by Kelsic Eric David and is headquartered in Watertown, MA.

Edifice Health, Inc. is a digital health spin-out company that offers a novel metric of inflammatory health, which is augmented with personalized health interventions to improve and extend healthspan. The company is based in San Mateo, CA. The company has solid underpinnings in immunological science and AI-powered technology. Edifice Health aims to tackle chronic diseases worldwide with a consumer and market-centric orientation. The company was founded by Mark M. Davis and David Furman.

IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation.